Latest insights

The Big Shrink – How to navigate High Yield markets?

Charudatta Shende, Nicolas Jullien, Fixed Income, Research Paper
High yield markets are shrinking. Do you know that they have contracted by 25% over the past two years? The ICE BofA BB-B Global High Yield Index has lost $654 million in value. In the meanwhile, investor demand for credit and high yield has rebounded at the end of last year.
  • Asset Allocation, Macro, Equities, Fixed Income, Nicolas Forest, Nadège Dufossé, Emile Gagna

    Update on Middle East Tensions

    On April 13, Iran decided to strike Israel with 300 drones and missiles following an attack on its diplomatic compound in Syria. Regional escalation and oil price are at risk. This tail risk cannot be ignored. We are closely monitoring the unfolding situation.
  • ESG, SRI, David Czupryna, Circular Economy, Article

    Beyond Fossil Fuels: Why Green Investments Are Still the Future

    After a challenging period for green investing, marked by rising interest rates, supply chain issues, and overcapacity, companies committed to building a sustainable world could remain an attractive long-term option for investors seeking both financial returns and positive impact.
6 results found
  • Oncology
Show me
  • Topic
  • Theme
  • Publication
  • Author
Find it fast
Show me
  • Topic
  • Theme
  • Publication
from
  • Author
6 results found
  • Oncology
Malgorzata Kluba, Rudi Van Den Eynde, Oncology, Equities

World Cancer Day 2023

And we would rather not have to go through this – which would mean we won the battle and cancer is curable.
Oncology, Q&A, Rudi Van Den Eynde, Equities

Investing in oncology: forewarned is forearmed

Rudi Van Den Eynde, Head of Thematic Global Equity at Candriam, explains to investors the approach he used to create and develop an investment strategy in the oncology sector.
Oncology

World Cancer Day: How PRISM is helping to Close the Gap

The Candriam Institute provides financial support to the PRecISion Medicine Institute. The PRISM technology aims to save an additional 200,000 lives each year by identifying the unique molecular characteristics of each patient's cancer.
Oncology, ESG, SRI

World Cancer Day: How PRISM is helping to Close the Gap

The Candriam Institute provides financial support to the PRecISion Medicine Institute. The PRISM technology aims to save an additional 200,000 lives each year by identifying the unique molecular characteristics of each patient's cancer. With this information, more targeted treatment can be applied at each step, improving survival rates.
Oncology

Fight against cancer: Let’s write another story together

While cancer is still striking hard and remains among the leading causes of death globally, pharmaceutical innovation is continuing at a high pace. The patients’ survival rate keeps increasing, as is our understanding of the disease and its multiple forms deepens, and as breakthrough therapies are tested and launched. 

Find it fast

Get information faster with a single click

Get insights straight to your inbox